Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits
NCT ID: NCT02751580
Last Updated: 2025-05-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2016-03-23
2018-08-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-time Activity Monitoring to Prevent Admissions During RadioTherapy
NCT03102229
A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
NCT00608751
Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19
NCT04357574
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
NCT02899221
Transportation for Cancer Care Navigation Tool for Reducing Travel Barriers Among Patients With Solid Tumors Receiving Radiation Therapy
NCT06541158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To examine feasibility of conducting a trial comparing a telehealth visit and an in person office visit.
SECONDARY OBJECTIVES:
I. To examine patient satisfaction, patient assessment of physician communication during a telehealth visit.
II. To examine patient distrust in the healthcare system following a telehealth visit.
III. To examine physician ability to perform a patient assessment during a telehealth visit.
IV. To examine physician perceptions of telehealth visits. V. To examine monetary and time cost to patients for telehealth visit. VI. To calculate clinic savings derived from telehealth visits.
OUTLINE:
Patients undergo their first post-treatment visit as a virtual telehealth visit using the JeffConnect application.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health services research (telehealth)
Patients undergo their first post-treatment visit as a virtual telehealth visit using the JeffConnect application downloaded onto their electronic device.
Telemedicine
Attend a virtual visit via the JeffConnect telehealth app
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemedicine
Attend a virtual visit via the JeffConnect telehealth app
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Karnofsky performance status (KPS) score \>= 60
* Patients must be capable to read and speak English and provide study specific informed consent prior to study entry
* Patients must have access to a computer or smartphone and internet connection at home on which they would be willing to do a telehealth study
* Pennsylvania or New Jersey residents \*Telehealth visits for New Jersey residents will only be performed by physicians with a current medical license issued by the state of New Jersey.
Exclusion Criteria
* No access to a computer, smartphone or internet
* Unable to read and/or speak English
* Decisionally impaired patients
* Patients not residing in Pennsylvania or New Jersey
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sidney Kimmel Cancer Center at Thomas Jefferson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicole Simone, MD
Role: PRINCIPAL_INVESTIGATOR
Thomas Jefferson University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Sidney Kimmel Cancer Center at Thomas Jefferson University, an NCI-Designated Cancer Center
Jefferson University Hospitals
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JT 8256
Identifier Type: OTHER
Identifier Source: secondary_id
15D.580
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.